“…While bacteriocins interacting synergistically with other antimicrobials and stressors could have great potential in clinical and food settings, one must be aware that unfortunately, bacteriocins are by no means a “magic bullet” and are not exempt from development of resistance (Modi et al, 2000; Draper et al, 2015). Indeed, several different mechanisms of resistance to the lantibiotic subclass of bacteriocins have been described, which include cell-envelope altering mechanisms utilized by bacteria such as DltA or MprF (Peschel et al, 1999; Poyart et al, 2001; Abachin et al, 2002; Kovacs et al, 2006; Khattar et al, 2009; McBride and Sonenshein, 2011a,b), two component systems such as CprK in C. difficile (McBride and Sonenshein, 2011a,b; Suarez et al, 2013) and LisRK in L. monocytogenes (Cotter et al, 1999; Kallipolitis and Ingmer, 2001), as well as other mechanisms such as production of nisin resistance proteins (Chatterjee et al, 2005; O'Driscoll et al, 2006; Khosa et al, 2013) (for a comprehensive review on lantibiotic resistance, see Draper et al, 2015).…”